Risk Prediction Models for Stroke and Myocardial Infarction in Patients with Type 2 Diabetes
[Speaker] 이승환/가톨릭의대
CV Benefit of SGLT2 Inhibitor: Cardiometabolic Mechanisms Beyond Its Hemodynamic Effect
[Speaker] 진상만/성균관의대
Cardiometabolic Benefit of Physically Active Lifestyle
[Speaker] 강시혁/서울의대
Discussion